Phase 3, randomized, double-blind, placebo-controlled, decentralized clinical trial estimated to take approximately 3.5 years to complete once fully enrolled FDA indicates. | June 10, 2021
Profit In A $29 Billion New Biotech Sector
I came of age in the late 1960s and early 1970s, which means I’m no stranger to recreational drugs, from pot to psychedelics. Like, I’ve seen things, man… and I could tell you some stories. Through it all, though, I was fascinated with the idea of psychedelics. I still am.
Tough to believe, but back then, LSD was still legal; research was going full-bore. And I understood these drugs had promise - real promise.
Please share this article - Go to very top of page, right hand side, for social media buttons.
Severe COVID-19 trial enrollment reaches 178 patients; interim analysis expected in Q3 At the FDA’s suggestion, planning to request a Type A meeting to.